Literature DB >> 17219134

Assessment of quantitative FDG PET data in primary colorectal tumours: which parameters are important with respect to tumour detection?

Ludwig G Strauss1, Sven Klippel, Leyun Pan, Klaus Schönleben, Uwe Haberkorn, Antonia Dimitrakopoulou-Strauss.   

Abstract

PURPOSE: The impact of quantitative parameters on the differentiation of primary colorectal tumours from normal colon tissue was assessed. Dynamic PET data (DPET) were acquired, and compartment and non-compartment modelling applied. The discriminant power of single parameters and the combination of PET parameters was assessed. All lesions were confirmed by histology.
METHODS: FDG DPET studies were acquired in 22 patients with colorectal tumours prior to surgery. Five of these patients also had liver metastases at the time of the PET study. The SUV 56-60 min p.i. was included in the evaluation. A two-tissue compartment model was applied and the parameters k1-k4 as well as the fractional blood volume (VB) were obtained. The FDG influx was calculated from the compartment data. Non-compartment modelling was used to calculate the fractal dimension (FD) of the time-activity data.
RESULTS: FD, SUV, influx and k3 were the most important single parameters for lesion differentiation. The highest accuracy was achieved for FD (88.78%). The overall tracer uptake was mainly dependent on k3 and not on k1 or VB. The support vector machines (SVM) algorithm was used to predict the classification based on the combination of individual PET parameters. The overall accuracy was 97.3%, with only one false positive case and no false negative results. The analysis of the subgroup of five patients with primary tumours and synchronous metastases revealed no significant differences for the individual PET parameters. However, VB tended to be lower while k1 and k2 were higher in patients with synchronous metastases. The SVM classification analysis predicted the presence of metastases based on the PET data of the primary tumour in three of five patients.
CONCLUSION: Quantitative FDG PET studies provide very accurate data for the differentiation of primary colorectal tumours from normal tissue. The use of quantitative data has the advantage that the detection of a colorectal tumour is not primarily dependent on the individual assessment and experience of the physician evaluating the FDG PET data only visually. The results suggest that the presence of metastatic lesions may be predicted by analysis of the dynamic PET data of the corresponding primary tumour. Further studies are needed to assess this aspect in detail.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17219134     DOI: 10.1007/s00259-006-0319-8

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   10.057


  26 in total

Review 1.  Update on gastrointestinal imaging.

Authors:  D Bradley Koslin
Journal:  Rev Gastroenterol Disord       Date:  2002

2.  Relevance vector machine for automatic detection of clustered microcalcifications.

Authors:  Liyang Wei; Yongyi Yang; Robert M Nishikawa; Miles N Wernick; Alexandra Edwards
Journal:  IEEE Trans Med Imaging       Date:  2005-10       Impact factor: 10.048

3.  Applications of support vector machines to cancer classification with microarray data.

Authors:  Feng Chu; Lipo Wang
Journal:  Int J Neural Syst       Date:  2005-12       Impact factor: 5.866

4.  Requirements and implementation of a flexible kinetic modeling tool.

Authors:  C Burger; A Buck
Journal:  J Nucl Med       Date:  1997-11       Impact factor: 10.057

5.  Local recurrence of rectal cancer: evaluation with F-18 fluorodeoxyglucose PET imaging.

Authors:  M T Keogan; V J Lowe; M E Baker; V G McDermott; H K Lyerly; R E Coleman
Journal:  Abdom Imaging       Date:  1997 May-Jun

6.  Noninvasive method to obtain input function for measuring tissue glucose utilization of thoracic and abdominal organs.

Authors:  T Ohtake; N Kosaka; T Watanabe; I Yokoyama; T Moritan; M Masuo; M Iizuka; K Kozeni; T Momose; S Oku
Journal:  J Nucl Med       Date:  1991-07       Impact factor: 10.057

7.  Quantitative assessment of SSTR2 expression in patients with non-small cell lung cancer using(68)Ga-DOTATOC PET and comparison with (18)F-FDG PET.

Authors:  Antonia Dimitrakopoulou-Strauss; Vassilios Georgoulias; Michael Eisenhut; Felix Herth; Sophia Koukouraki; Helmut R Mäcke; Uwe Haberkorn; Ludwig G Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-29       Impact factor: 9.236

Review 8.  The applications of PET in clinical oncology.

Authors:  L G Strauss; P S Conti
Journal:  J Nucl Med       Date:  1991-04       Impact factor: 10.057

9.  Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading.

Authors:  A Dimitrakopoulou-Strauss; L G Strauss; M Schwarzbach; C Burger; T Heichel; F Willeke; G Mechtersheimer; T Lehnert
Journal:  J Nucl Med       Date:  2001-05       Impact factor: 10.057

10.  18F-FDG kinetics and gene expression in giant cell tumors.

Authors:  Ludwig G Strauss; Antonia Dimitrakopoulou-Strauss; Dirk Koczan; Ludger Bernd; Uwe Haberkorn; Volker Ewerbeck; Hans-Jürgen Thiesen
Journal:  J Nucl Med       Date:  2004-09       Impact factor: 10.057

View more
  26 in total

1.  Application of (18)F-fluorodeoxyglucose positron emission tomography to detection of proximal lesions of obstructive colorectal cancer.

Authors:  Shusuke Mori; Kazuhiro Oguchi
Journal:  Jpn J Radiol       Date:  2010-10-24       Impact factor: 2.374

2.  Can PET-CT with FDG replace contrast enhanced CT for imaging of liver metastases?

Authors:  Ludwig G Strauss; Antonia Dimitrakopoulou-Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12       Impact factor: 9.236

3.  The role of 18F-FLT in cancer imaging: does it really reflect proliferation?

Authors:  Antonia Dimitrakopoulou-Strauss; Ludwig G Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 9.236

4.  Clinical Value of a One-Stop-Shop Low-Dose Lung Screening Combined with (18)F-FDG PET/CT for the Detection of Metastatic Lung Nodules from Colorectal Cancer.

Authors:  Yeon-Hee Han; Seok Tae Lim; Hwan-Jeong Jeong; Myung-Hee Sohn
Journal:  Nucl Med Mol Imaging       Date:  2015-12-17

5.  PET/CT studies of multiple myeloma using (18) F-FDG and (18) F-NaF: comparison of distribution patterns and tracers' pharmacokinetics.

Authors:  Christos Sachpekidis; Hartmut Goldschmidt; Dirk Hose; Leyun Pan; Caixia Cheng; Klaus Kopka; Uwe Haberkorn; Antonia Dimitrakopoulou-Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-22       Impact factor: 9.236

Review 6.  Dynamic whole-body PET imaging: principles, potentials and applications.

Authors:  Arman Rahmim; Martin A Lodge; Nicolas A Karakatsanis; Vladimir Y Panin; Yun Zhou; Alan McMillan; Steve Cho; Habib Zaidi; Michael E Casey; Richard L Wahl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-29       Impact factor: 9.236

7.  Combined use of (18)F-FDG and (18)F-FMISO in unresectable non-small cell lung cancer patients planned for radiotherapy: a dynamic PET/CT study.

Authors:  Christos Sachpekidis; Christian Thieke; Vasileios Askoxylakis; Nils H Nicolay; Peter E Huber; Michael Thomas; Georgia Dimitrakopoulou; Juergen Debus; Uwe Haberkorn; Antonia Dimitrakopoulou-Strauss
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-01-15

8.  (18)F-Deoxyglucose (FDG) kinetics evaluated by a non-compartment model based on a linear regression function using a computer based simulation: correlation with the parameters of the two-tissue compartment model.

Authors:  Ludwig G Strauss; Leyun Pan; Caixia Cheng; Antonia Dimitrakopoulou-Strauss
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-10-15

Review 9.  18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization.

Authors:  Hossein Jadvar; Abass Alavi; Sanjiv S Gambhir
Journal:  J Nucl Med       Date:  2009-10-16       Impact factor: 10.057

10.  11C-methionine-PET for evaluation of carbon ion radiotherapy in patients with pelvic recurrence of rectal cancer.

Authors:  Mitsuru Koizumi; Tsuneo Saga; Kyosan Yoshikawa; Kazutoshi Suzuki; Shigeru Yamada; Mitsuhiko Hasebe; Seiya Ohashi; Sherif Abd-Elrazek; Hiroyuki Ishikawa; Kenji Sagou; Katsumi Tamura; Ryusuke Hara; Hirotoshi Kato; Shigeo Yasuda; Takeshi Yanagi; Hirohiko Tsujii
Journal:  Mol Imaging Biol       Date:  2008-08-05       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.